Mapping cellular heterogeneity and dynamic interactions in pancreatic cancer
Journal of Controlled Release · 2026-05 · 393 · 114757
DOI: 10.1016/j.jconrel.2026.114757 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2026-05. Verfasst von Tatekalva Sandhya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science, Sri Venkateswara University, Tirupati, 517502, AP, India. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 138 Literaturangaben.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive with a high mortality rate. Intra-tumoral heterogeneity (ITH) increases the severity of PDAC and makes treatment difficult. Insights are provided on ITH to understand the diversity of microenvironment (ME) components, biomarkers, different subsets of tumor-associated cells, and immune cells, as well as metabolic reprogramming, autophagy, and apoptosis in PDAC. Single-cell RNA sequencing (scRNA-seq) is a sensitive technique that provides spatially resolved transcriptomic profiling. In this review, we discussed the sample preparation, library preparation, data analysis, and challenges associated with the technology. We have outlined a stepwise process workflow that utilizes computational approaches based on experimental requirements, supported by relevant examples and discussion. We reviewed various studies where scRNA-seq has helped identify dynamic cell subset transformations during tumorigenesis, modulate ME, epithelial-mesenchymal transition, and cancer stem cells enrichment, and identify novel signaling molecules, prognostic gene markers, and therapeutic vulnerabilities for PDAC. Identification of biomarkers such as Matrix metalloproteinase 1 (MMP1) and the S100A2+ tumor subset, characterization of the basal-like malignant subtype, and interventions like radiofrequency ablation reshaping the PDAC-ME were also discussed. Additionally, the roles of cancer associated fibroblasts and the therapeutic potential inhibitors in combination with signal transducer and activator of transcription 3 blockade and anti-CD47/anti-PD-L1 immunotherapy were reviewed in preventing PDAC resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Computer Science, Sri Venkateswara University, Tirupati, 517502, AP, India.
- Department of Biotechnology, Dr.B.R. Ambedkar University, Srikakulam, 532410, AP, India.
- Department of Biotechnology, Sri Padmavati Mahila Visvavidyalayam, Women's University, Tirupati 517502, Andhra Pradesh, India.
- School of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
- School of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA. Electronic address: pganji@uab.edu.
- Department of Biotechnology, Sri Venkateswara University, Tirupati, 517502, AP, India. Electronic address: latha_suresh@ymail.com.
Zitieren
APA
Sandhya, T., Kumari, S., Meghapriya, A., Manam, V. K. C., Nagaraju, G. P., & Srilatha, M. (2026). Mapping cellular heterogeneity and dynamic interactions in pancreatic cancer. Journal of Controlled Release, 393, 114757. https://doi.org/10.1016/j.jconrel.2026.114757
Vancouver
Sandhya T, Kumari S, Meghapriya A, Manam VKC, Nagaraju GP, Srilatha M. Mapping cellular heterogeneity and dynamic interactions in pancreatic cancer. Journal of Controlled Release. 2026;393:114757. doi:10.1016/j.jconrel.2026.114757
BibTeX
@article{Sandhya2026,
author = {Sandhya, Tatekalva and Kumari, Seema and Meghapriya, Adem and Manam, V K Chaithanya and Nagaraju, Ganji Purnachandra and Srilatha, Mundla},
title = {Mapping cellular heterogeneity and dynamic interactions in pancreatic cancer},
journal = {Journal of Controlled Release},
year = {2026},
volume = {393},
pages = {114757},
doi = {10.1016/j.jconrel.2026.114757}
}
EUVIMED